Efficacy of 5 × 5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression
Journal of Affective Disorders · 2026-06 · 403 · 121345
DOI: 10.1016/j.jad.2026.121345 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Affective Disorders, 2026-06. Verfasst von Michael R Apostol und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at University of California, 757 Westwood Plaza #4, Los Angeles, C…. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant, Major Depressive Disorder. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, University of California, Los Angeles, National Institute of Mental Health.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Accelerated repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for Major Depressive Disorder (MDD), with an FDA-cleared protocol utilizing 10 sessions of prolonged intermittent Theta Burst Stimulation (piTBS) per day for five days. However, it remains unclear how many sessions and pulses are necessary to achieve benefit. METHODS: In a retrospective analysis of clinical data, we examined efficacy of five rTMS stimulation sessions per day for five days ("5 × 5") (N = 40) of either piTBS or individualized, electroencephalogram-based "resonant frequency" (RF) stimulation, and used mixed-effects linear models to compare these accelerated protocols to a standard once-daily rTMS protocol where patients received one rTMS session per day, 5 days a week, for 6 weeks (N = 135). RESULTS: Both protocols ameliorated MDD symptoms and there were no statistically significant differences in depression symptom changes (p = 0.07) between the accelerated 5 × 5 protocol (mean PHQ-9: pre-rTMS = 17.68, post-rTMS = 10.98) and conventional once-daily treatment (mean PHQ-9: pre-rTMS = 17.83, post-rTMS = 8.97) at treatment completion (treatment day 5 for the 5 × 5 patients and treatment day 30 for the conventional patients). There was no significant difference in improvement between the piTBS and RF 5 × 5 protocols (p = 0.9). A PHQ-9 median split of 5 × 5 patients revealed that the top half of patients showed robust depression improvement (69%) while the bottom half received no significant benefit (8%) by day 5. However, the bottom half showed significant improvement (36%) at two-to-four-week follow up (p = 0.001). CONCLUSIONS: These results suggest 5 × 5 accelerated rTMS treatment may be as effective as once daily rTMS treatment for many patients, and should be explored in future randomized clinical trials. It is critical to perform prolonged follow-up assessments in such trials because the efficacy of accelerated treatment may not be accurately assessed until weeks after treatment completion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at University of California, 757 Westwood Plaza #4, Los Angeles, CA, 90095, USA. Electronic address: michaelrapostol@ucla.edu.
- Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at University of California, 757 Westwood Plaza #4, Los Angeles, CA, 90095, USA; TMS Clinical and Research Service, Neuromodulation Divi…
- Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at University of California, 757 Westwood Plaza #4, Los Angeles, CA, 90095, USA.
Förderung
- NIMH NIH HHS
- University of California, Los Angeles
- National Institute of Mental Health
Zitieren
APA
Apostol, M. R., Valles, T. E., Corlier, J., Leuchter, M. K., Young, A. S., Artin, H., Koek, R. J., Einstein, E. H., Wilke, S. A., Oughli, H. A., Strouse, T., Slan, A., Distler, M. G., DeYoung, D. Z., Ginder, N., Krantz, D. E., & Leuchter, A. F. (2026). Efficacy of 5 × 5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression. Journal of Affective Disorders, 403, 121345. https://doi.org/10.1016/j.jad.2026.121345
Vancouver
Apostol MR, Valles TE, Corlier J, Leuchter MK, Young AS, Artin H, et al. Efficacy of 5 × 5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression. Journal of Affective Disorders. 2026;403:121345. doi:10.1016/j.jad.2026.121345
BibTeX
@article{Apostol2026,
author = {Apostol, Michael R and Valles, Thomas E and Corlier, Juliana and Leuchter, Michael K and Young, Alexander S and Artin, Hewa and Koek, Ralph J and Einstein, Evan H and Wilke, Scott A and Oughli, Hanadi A and Strouse, Thomas and Slan, Aaron and Distler, Margaret G and DeYoung, Dustin Z and Ginder, Nathaniel and Krantz, David E and Leuchter, Andrew F},
title = {Efficacy of 5 × 5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {403},
pages = {121345},
doi = {10.1016/j.jad.2026.121345}
}
EUVIMED